ライフサイエンスコーパス: intramyocellular lipid

1 he expression of BMPs, inflammation, HO, and intramyocellular lipid accumulation in both skeletal and

2 itivity, mitochondrial function, hepatic and intramyocellular lipid accumulation, cardiac energy stat

3 function, which predisposes IR offspring to intramyocellular lipid accumulation, which in turn activ

4 rate that burn injury results in a localized intramyocellular lipid accumulation, which in turn is ac

5 ed by etomoxir, in the presence of increased intramyocellular lipid accumulation.

6 In addition, intramyocellular lipid and HTG contents were measured by

7 ectroscopy studies were performed to measure intramyocellular lipid and intrahepatic triglyceride con

8 ut exercise on skeletal muscle mitochondria, intramyocellular lipids, and insulin sensitivity index (

9 s between BMI and unsaturated fatty acids in intramyocellular lipids, and methylene groups in extramy

10 magnetic resonance imaging and muscle lipid (intramyocellular lipid) by proton magnetic resonance spe

11 Increased intramyocellular lipid concentrations are thought to pla

12 s with impaired glucose tolerance had higher intramyocellular lipid content (3.04 [0.43] vs 1.99 [0.1

13 Intramyocellular lipid content (IMCL) can be elevated in

14 Intramyocellular lipid content (IMCL) is elevated in ins

15 increased intrahepatic lipid content (IHL), intramyocellular lipid content (IMCL), and low circulati

16 me (P = .9), myocardial TG content (P = .9), intramyocellular lipid content (P = .3), or cardiac func

17 increase of approximately 80 percent in the intramyocellular lipid content (P=0.005).

18 es and is strongly associated with increased intramyocellular lipid content and inflammation.

19 ed with an approximately 60% increase in the intramyocellular lipid content as assessed by H magnetic

20 This increase in intramyocellular lipid content was most likely attributa

21 iated with increases in hepatic (HTG) and/or intramyocellular lipid content, little is known about th

22 Recent studies have demonstrated increased intramyocellular lipid, decreased mitochondrial ATP synt

23 tion this is avoidable, given that causes of intramyocellular lipid deposition are predominantly life

24 fetuin-A, body composition, pancreatic fat, intramyocellular lipids, fecal SCFAs, blood pressure, or

25 A levels of regulatory components related to intramyocellular lipid, glucose metabolism and fiber siz

26 skeletal muscle as a predisposing factor for intramyocellular lipid (IMCL) accumulation and muscle in

27 To examine the role of intramyocellular lipid (IMCL) accumulation as well as ci

28 Intramyocellular lipid (IMCL) accumulation is postulated

29 Insulin resistance is closely related to intramyocellular lipid (IMCL) accumulation, and both are

30 scle fibers would exhibit similar changes in intramyocellular lipid (IMCL) and extramyocellular lipid

31 resistance correlates more tightly with the intramyocellular lipid (IMCL) concentration than with an

32 This study compared soleus intramyocellular lipid (IMCL) concentrations after consu

33 Intrahepatic lipid (IHL) and intramyocellular lipid (IMCL) concentrations were determ

34 onal studies have shown correlations between intramyocellular lipid (IMCL) content and muscle strengt

35 mass, fiber type, cross-sectional area, and intramyocellular lipid (IMCL) content.

36 ABSTRACT: Intramyocellular lipid (IMCL) hampers insulin sensitivit

37 Excessive intramyocellular lipid (IMCL) storage exceeds intracellu

38 ydrate and fat as precursors of glycogen and intramyocellular lipid (IMCL) synthesis.

39 The correlations between intramyocellular lipid (IMCL), decreased fatty acid oxid

40 taneous (SAT) adipose tissue, liver fat, and intramyocellular lipids (IMCL) in 101 Chinese, 82 Malays

41 one marrow fat content, of soleus muscle for intramyocellular lipids (IMCL), and liver for intrahepat

42 metabolism, resulting in increased levels of intramyocellular lipids (IMCLs) and lipid intermediates,

43 lin resistant, demonstrated higher levels of intramyocellular lipids (IMCLs), and expressed approxima

44 ance have been linked to accumulation of the intramyocellular lipid-intermediate diacylglycerol (DAG)

45 Persistent elevation of intramyocellular lipid intermediates, likely resulting f

46 Abdominal adipose tissue volume and intramyocellular lipid levels were comparable between 8-

47 pecific skeletal muscle proteins involved in intramyocellular lipids, mitochondrial oxidative capacit

48 ent understanding of the effects of elevated intramyocellular lipids on insulin signaling and how the

49 scriptional oxidative phenotype, and altered intramyocellular lipid partitioning and may therefore be

50 es were to examine saturated and unsaturated intramyocellular lipid pool turnover.

51 conclude that insulin-resistant, maladapted intramyocellular lipid storage and turnover in patients

52 KEY POINTS: Intramyocellular lipid storage is negatively associated

53 The primary outcomes were to assess intramyocellular lipid storage of the vastus lateralis i

54 Intramyocellular lipid was assessed by proton nuclear ma

55 esonance imaging, and intrahepatic lipid and intramyocellular lipid were assessed by proton magnetic

56 by a high oxidative capacity, have elevated intramyocellular lipids, yet are highly insulin sensitiv